Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Before investing in cryptocurrency, it's crucial to understand the market. Learn key insights to prepare yourself for potential investments.
24,812 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
BTIG raises its price target on FTAI Aviation after the company boosted 2026 EBITDA guidance, arguing that a recoveri...
The U.K. edition of Saturday Night Live is renewed for a second season, underscoring a new model where social-clip vi...
A Seoul hotel launches a robot napkin-folding pilot, part of a broader push into physical AI that blends staff skills...
Cisco beat estimates on a robust AI infrastructure push, delivering record revenue and higher AI targets as the stock...
A fresh study presented at Gartner's Data & Analytics Summit argues that attaching semantic meaning to data could dra...
NVDL plunged sharply in early 2025 as daily rebalancing magnified losses, even as NVDA fell less. Analysts warn this ...
Traders online are buzzing about turns $100k $1.28m year as a 3x semiconductor play surged over the last 12 months. T...
Small-cap value has accelerated ahead of growth in 2026, with three ETFs leading the pack by delivering a clear facto...
Mortgage Forward has signed a definitive agreement to purchase First Federal Bank's third-party origination unit, exp...
The U.S. emergency oil stockpile is near its lowest level since 1983, with continued releases and global supply disru...
A disrupted energy flow landscape is lifting a U.S. midstream stock and with it the focus on safe, high-yield income....